弥漫性毒性甲状腺肿(Graves病)是内分泌常见疾病,白细胞减少/缺乏是Graves病常见的合并症之一,可以发生在治疗之前和抗甲状腺药物治疗之后,在临床上经常被延误诊断和治疗,有时导致严重感染而使病情加重。本文就近几年来的研究进展,主要对其诊断、发病机制和治疗方面进行综述,着重论述临床如何早期发现与及时治疗。
Graves disease is one of the most common endocrine diseases. Leucopenia or agranulocytosis can be coexistent with Graves' disease in some patients.It can be seen in patients before treatment and after anti-thyroid medication. This phenomenon is often delayed in clinical diagnosis and treatment,which sometimes causes serious infections and makes the disease worse. According to the research progress in the recent years, including the diagnosis, pathogenesis and treatment about the desease, the authors aim to show early discovery and timely treatment in patients with Graves’ disease presenting with leucopenia or agranulocytosis.
[1] 中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南[J].中华内科杂志,2007,46(10):876-882.
[2] 关晓燕,包建玲,李巍.初诊Graves′甲亢患者合并白细胞减少的研究[J].国际检验医学杂志,2015,36(6):835-837.
[3] Cooper DS, Goldminz D, Levin AA, et al. Agranulocytosis associated with antithyroid drugs[J]. Ann Intern Med,1983,98(1):26-29.
[4] Young GAR, Vincent PC. Drug-induced agranulocytosis[J]. Clin Haematol,1980,9(3): 483-504.
[5] Tajiri J, Noguchi S, Murakami T,et al. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring[J]. Arch Intern Med,1990, 150(3):621.
[6] Tamai H, Takaichi Y, Morita T, et al. Methimazole-induced agranulocytosis in Japanese patients with Graves' disease[J]. Clin Endocrinol,1989,30(5): 525-530.
[7] Guffy MM, Goeken NE, Bruno CP. Granulocytotoxic antibodies in a patient with propylthiouracil-induced agranulocytosis[J]. Arch Intern Med, 1984, 144(8): 1687-1688.
[8] Weitzman SA,Stossel TP, Harmon DC,et al. Antineutrophil autoantibodies in Graves′disease. Implications of thyrotropin binding to neutrophils[J].J Clin Invest,1985,75(1): 119-123.
[9] Yamada T,Sato A,Aizawa T,et al.An elevation of stem cell factor in patients with hyperthyroid Graves′disease[J]. Thyroid,1998, 8(6): 499-504.
[10] Diez S,Banias H,Diez-Martin JL,et al.Apparent cure of Graves-Basedow disease after sibling allogeneic bone marrow transplantation[J].Clin Endocrinol,1999,50(2):267-270.
[11] 李梅,邱明才,李欣,等.Graves病合并白细胞减少患者血清对骨髓细胞粒-单核细胞系集落形成单位生长的影响[J].中华实用医学杂志,2002,82(9):643-645.
[12] 邹大进,李娟.甲状腺功能亢进症伴粒细胞减少的诊断与处理[J].中国实用内科杂志,2006,26(9):645-646.
[13] 田竹芳,华郁.Graves病患者血液学异常的特点及相关因素分[J]析.中国全科医学,2010,13(3B):855-856.
[14] 刘迎见,施秉银,李娟.Graves甲亢合并白细胞减少与甲状腺自身抗体相关性研究[J].山东医药,2010,50(17):58-59.
[15] Takata K,Kubota S,Fukata S,et al.Methimazole-induced agranulocytosis in patients with Graves′ disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily[J].Thyroid,2009,19(6):559-563.
[16] Shiran A, Shechner C, Dickstein G. Propylthiouracil-induced agranulocytosis in four patients previously treated with the drug[J]. JAMA,1991,266(22):3129-3130.
[17] 吴嘉俐.甲状腺功能亢进症合并白细胞减少60例临床观察[J].华中医学杂志,2008,32(5):367.
[18] Tamai H, Sodo T, Kimura A, et al.Association between the DRB1＊08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease[J]. Am Intern Med, 1996, 124(5): 490-494.
[19] Douer D, Eisenstein Z. Methimazole-induced agranulocytosis: growth inhibition of myeloid progenitor cells by the patient ′s serum[J]. Eur J Haematol, 1988, 40(1):91-94.
[20] 高云明,汤建雷,周萍,等.ATD对GD患者粒细胞分布的影响[J].医学研究杂志,2013,42(8):130-132.
[21] Fukata S,Murakami Y,Kuma K,et al. G-CSF levels during spontaneous recovery from drug-induced agranulocytosis[J]. Lancet,1993,342(8885):1495.
[22] Tajiri J,Noguchi S,Murakami N. Usefulness of granulocyte count measurement four hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia[J].Thyroid,1997,7(4): 575-578.
[23] Vyas AA,Vyas P,Fillipon NL,et al.Successful treatment of thyroid storm with plasmapheresis in a patient with methimazole-induced agranulocytosis[J]. Endocr Pract,2010,16(4): 673-676.
